Skip to content

Clinical trials

Observational Heart Failure trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Observational Country / region: Hong Kong Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20101
20111
20121
20141
20183
20222
20233
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Not yet recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong5
Boston Scientific Corporation3
Medtronic Cardiac Rhythm and Heart Failure2
The University of Hong Kong2
Abbott Medical Devices1
AstraZeneca1
Biotronik SE & Co. KG1
Carolyn Lam1
Medtronic1
Respicardia, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure18
Bradycardia3
Cardiomyopathies2
Edema2
Heart Defects, Congenital2
Heart Diseases2
Hypertension, Pulmonary2
Tachycardia, Ventricular2
Arrhythmias, Cardiac1
Bundle-Branch Block1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.